Literature DB >> 12422228

Molecular basis of inherited predispositions for tumors.

Jan Lubiński1, Bohdan Górski, Grzegorz Kurzawski, Anna Jakubowska, Cezary Cybulski, Janina Suchy, Tadeusz Debniak, Ewa Grabowska, Marcin Lener, Katarzyna Nej.   

Abstract

On the basis of literature data and own experience the authors review the current knowledge about the molecular basis of inherited predispositions for tumors. They hypothesize that in the near perspective 5-10 years studies using existing registry data/material and the latest novel technology will allow the identification of the molecular background for the majority of hereditary cancers which will have enormous practical consequences especially for the prevention of malignancies.

Entities:  

Mesh:

Year:  2002        PMID: 12422228     DOI: 024903571

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  4 in total

1.  Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer.

Authors:  Aleksandra Tołoczko-Grabarek; Andrzej Sikorski; Marek Brzosko; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2005-08-15       Impact factor: 2.857

2.  DNA and RNA analyses in detection of genetic predisposition to cancer.

Authors:  Joanna Matyjasik; Bartlomiej Masojc; Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

3.  DNA and RNA analyses in detection of genetic predisposition to cancer.

Authors:  Grzegorz Kurzawski; Dagmara Dymerska; Pablo Serrano-Fernández; Joanna Trubicka; Bartłomiej Masojć; Anna Jakubowska; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2012-12-04       Impact factor: 2.857

4.  Comparison of whole genome amplification and nested-PCR methods for preimplantation genetic diagnosis for BRCA1 gene mutation on unfertilized oocytes-a pilot study.

Authors:  Danuta Michalska; Kinga Jaguszewska; Joanna Liss; Kamila Kitowska; Agata Mirecka; Krzysztof Łukaszuk
Journal:  Hered Cancer Clin Pract       Date:  2013-08-13       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.